A Study to Evaluate Tabelecleucel in Participants With Epstein-barr Virus-associated Diseases
Conditions:   Epstein-Barr Virus (EBV)-Associated Diseases;   EBV+ Lymphoproliferative Disease With Primary Immunodeficiency (PID LPD);   EBV+ Lymphoproliferative Disease With Acquired (Non-congenital) Immunodeficiency (AID LPD);   EBV+ Posttransplant Lymphoproliferative Disease in Central Nervous Syste m (CNS PTLD);   EBV+ Post-transplant Lymphoproliferative Disease (EBV+ PTLD);   Solid Organ Transplant Complications;   Lymphoproliferative Disorders;   Allogeneic Hematopoietic Cell Transplant;   Stem Cell Transplant Complications;   EBV+ Sarcomas;   Leiomyosarcoma;   Chronic Ac tive Epstein-Bar...
Source: ClinicalTrials.gov - September 18, 2020 Category: Research Source Type: clinical trials